CLINICAL ROLE -
Board’s License Revocation Hearing Is Conducted Without Pharmacist Participating
Multiple requests for delays had been submitted.
Ensuring Innovation Act Changes Eligibility for New Chemical Exclusivity
Law aims to encourage competition in the pharmaceutical industry, making it easier for generics to enter market.
Federal ECHO Act Helps Goal of Health Equity
Expanding capacity of health care outcomes statutes aims to link specialists with general practices.
Kevin’s Law Makes 72-Hour Supply of More Medication Available to Patients
Eighteen states have enacted legislation that allows pharmacists to help patients when providers are not reachable.
Telehealth Proves of Great Value During COVID-19
But state-to-state communications and inconsistencies related to licensing present legal issues.
Failure to Conduct DUR Is Basis for Negligence Suit
Expectations for pharmacists related to drug utilization reviews lead to examination of woman's death.
Good Samaritan Laws Aim to Encourage Assistance
But in real-world situations, such as when a bystander administers naloxone, there are gray areas.
Pharmacy Receives DEA Immediate Suspension of Registration
Court challenge raises questions about due process and whether agency perceived immediate and serious threat.
Pharmacist Ignores “Hard Stop” in Computer
Physician expert witness excluded from testifying about standard of care in resulting lawsuit.
Nevada Addresses Costs for Diabetes Supplies
Manufacturers file challenge in court resulting in compromise between state government and pharmaceutical companies.
2 Clarke Drive Cranbury, NJ 08512